Delivery Order SPE2DB22D1103-SPE2DB25FH2K5
- Not listed
- The Defense Logistics Agency awarded a $5,061.00 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price contract was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and represents a non-set-aside competitive award. The delivery order is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a purchase under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract carries no...
- The Defense Logistics Agency awarded a delivery order valued at $20,761.43 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on June 2, 2025, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order is valued at $13,647.57 with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and was competitively awarded through the federal procurement process. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $17,846.50 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,937.20 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price procurement with no set-aside designation. The contract was competitively awarded and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $28,511.98 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 11, 2025, with completion targeted for August 12, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used to treat rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed pricing with no set-aside designation, indicating open competition. The product will be supplied to the place of performance in Conshohocken,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2K5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,814.85 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and was awarded competitively without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.999 billion global pharmaceutical support vehicle valued through December 2026. This prime IDC enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of federal medical procurement capabilities and consistently performs competitively awarded contracts with firm fixed pricing structures across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 9/16/25 |